Muscle as Medicine: How Skeletal Muscle Drives Metabolic Health

Introduction

Skeletal muscle is 40% of body weight in a healthy adult and consumes roughly 80% of post-meal glucose. It’s also an endocrine organ that secretes hundreds of signaling molecules, called myokines, in response to contraction. Losing muscle isn’t a cosmetic issue. It’s a metabolic one.

For people on GLP-1 medications, this matters more than for anyone. The drugs work by reducing food intake, and the resulting weight loss includes lean tissue. Body composition data from STEP 1 and SURMOUNT-1 shows that 25% to 40% of the lost mass is typically lean, with muscle making up the largest share of that loss.

Preserving muscle during weight loss isn’t optional if you want the metabolic benefits to last. Lower muscle mass means slower resting metabolism, worse insulin sensitivity, and a higher risk of weight regain when the medication stops.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

Why Is Skeletal Muscle Considered an Endocrine Organ?

The endocrine view of muscle started gaining traction in the early 2000s when researchers discovered that exercising muscle releases signaling molecules into circulation. Bente Pedersen’s lab in Copenhagen coined the term “myokine” in 2007 to describe IL-6 release during exercise.

Quick Answer: Skeletal muscle handles roughly 80% of insulin-stimulated glucose uptake after meals

Since then, the list has grown to over 600 candidate myokines, with dozens having confirmed roles in inter-organ signaling. Myokines act on adipose tissue, liver, bone, immune cells, and brain. Some are released constantly, others only during exercise.

The functional consequence is that muscle isn’t just a passive consumer of glucose and amino acids. It’s an active regulator of systemic metabolism. Lose muscle mass and you lose part of that regulatory capacity.

What Are the Most Important Myokines?

IL-6 from muscle is the prototype. Released during exercise, it acts differently than the chronic, inflammation-driven IL-6 from adipose tissue. Muscle-derived IL-6 promotes glucose uptake, fatty acid oxidation, and anti-inflammatory signaling.

BDNF, brain-derived neurotrophic factor, is released by both muscle and brain during exercise. It supports neuronal survival, synaptic plasticity, and is one mechanism by which exercise protects against cognitive decline.

FGF21 from muscle and liver promotes fat oxidation and improves insulin sensitivity. Irisin, discussed in detail elsewhere, drives white-to-beige fat conversion in mice and probably modestly in humans.

Decorin, myonectin, and METRNL are newer additions to the myokine list with effects on inflammation, lipid handling, and brown fat thermogenesis.

How Does Muscle Handle Blood Glucose?

After a meal, blood glucose rises and pancreatic beta cells release insulin. Insulin binds receptors on muscle cells and triggers the translocation of GLUT4 transporters to the cell membrane. GLUT4 then pulls glucose into the muscle, where it’s either burned for energy or stored as glycogen.

Muscle accounts for roughly 80% of insulin-stimulated glucose disposal, per a classic 1981 NEJM paper by DeFronzo et al. This is why insulin resistance often manifests first in skeletal muscle. When muscle stops responding to insulin, blood glucose stays elevated.

More muscle mass means more GLUT4, more glycogen storage capacity, and better postprandial glucose handling. This is part of why resistance-trained individuals have better insulin sensitivity even at similar body fat percentages.

What Does GLP-1 Weight Loss Do to Muscle?

The STEP 1 trial body composition substudy, published in Diabetes, Obesity and Metabolism by Wilding et al. in 2021, used DXA scans to track changes during 68 weeks of semaglutide 2.4 mg. Average weight loss was 14.9% of body weight. Of that, 39% was lean mass and 61% was fat mass.

SURMOUNT-1 imaging data on tirzepatide 15 mg showed similar proportions, with about 33% to 40% of the 20.9% total weight loss coming from lean tissue. The proportion is comparable to what’s seen in calorie-restricted diets without medication, which suggests the lean loss is driven by the caloric deficit itself rather than something specific to GLP-1.

The clinical question is whether that lean loss matters. For someone with abundant muscle reserves and good baseline function, losing 4 to 5 kg of muscle alongside 8 to 10 kg of fat is acceptable. For an older patient with sarcopenia or someone already underbuilt, the same proportion is a problem.

How Can I Preserve Muscle During GLP-1 Therapy?

Two interventions have strong evidence. The first is adequate protein. The 2024 ESPEN position paper on protein needs during weight loss recommends 1.2 to 1.6 grams per kilogram of body weight per day, distributed across 3 to 4 meals. That’s higher than the standard RDA of 0.8 g/kg.

The second is resistance training. A 2023 Sports Medicine meta-analysis by Murphy et al. pooled 67 trials of caloric deficit with or without resistance training. Adding resistance training preserved roughly 80% of lean mass that would otherwise have been lost.

The combination works better than either alone. Two to three full-body resistance sessions per week, focused on compound movements like squats, presses, rows, and deadlifts, is the practical target.

Does GLP-1 Itself Affect Muscle Metabolism?

GLP-1 receptors are expressed at low density in skeletal muscle, so direct effects are minimal. The lean mass loss is almost entirely an indirect consequence of the caloric deficit.

A few preclinical studies suggest GLP-1 agonism may have small effects on muscle protein synthesis or insulin sensitivity, but the human data is sparse. In practice, you should treat semaglutide and tirzepatide as appetite-modulating drugs that produce a calorie deficit, and plan muscle preservation as you would for any other weight-loss intervention.

The newer dual and triple agonists may add ingredients that affect muscle more directly. Bimagrumab, an activin receptor antagonist being studied in combination with GLP-1s, preserves or builds muscle during weight loss. Phase 2 data is promising but not yet definitive.

What’s the Sarcopenia Risk?

Sarcopenia is the age-related loss of muscle mass and function. By age 80, adults have typically lost 30% to 40% of the muscle they had at age 30. Combining age-related sarcopenia with medication-induced weight loss can accelerate functional decline.

Patients over 65 starting a GLP-1 should be screened for baseline muscle status. Grip strength, gait speed, and a DXA scan provide a useful starting picture. Slower titration, higher protein targets, and consistent resistance training are reasonable for older patients.

The cost-benefit still usually favors GLP-1 therapy in older patients with obesity, given the cardiovascular and metabolic benefits. The point isn’t to avoid the drug but to use it with appropriate attention to muscle.

Key Takeaway: The SURMOUNT-1 imaging analysis found similar lean mass loss with tirzepatide

How Do You Build Muscle on a GLP-1?

Building muscle during a caloric deficit is harder than preserving it but not impossible. Untrained individuals can gain meaningful muscle in their first year of resistance training even while losing fat, a phenomenon called body recomposition.

Trained individuals have more difficulty. For someone with years of training history, a slight caloric surplus or maintenance is usually needed to add muscle, which conflicts with active weight loss. The practical approach is to focus on muscle preservation during the weight-loss phase, then shift to muscle building during maintenance.

A personalized TrimRx plan can help match the medication phase to a lifestyle program that includes appropriate protein and training targets. The treatment isn’t separate from the gym work.

What Blood Markers Track Muscle Health?

Direct biomarkers of muscle mass are limited. Creatine kinase rises with muscle damage but isn’t a steady-state measure. Myostatin and follistatin can be measured but aren’t routinely available.

Better tools for tracking muscle health include DXA scans every 6 to 12 months, bioelectrical impedance for trend data, grip strength, and functional tests like the 5-times sit-to-stand or 6-minute walk. Sustained increases in resistance training loads also indicate muscle preservation or growth.

For metabolic health indirectly tied to muscle, fasting insulin, HbA1c, and a fasting glucose-to-insulin ratio give useful context. Lower fasting insulin in particular often tracks with better muscle insulin sensitivity.

How Do Age and Sex Affect Muscle Preservation During GLP-1 Therapy?

Women generally have lower baseline muscle mass than men and may lose a slightly higher proportion of lean tissue during weight loss. The STEP 4 maintenance data showed comparable lean mass dynamics between sexes, but the absolute amount of muscle lost was smaller in women simply because they had less to start with.

Postmenopausal women are at higher risk because of estrogen loss, which itself accelerates muscle and bone decline. Resistance training and adequate protein become especially important in this group. Hormone replacement therapy, when appropriate, can help preserve lean tissue, but that’s a separate clinical decision.

Older men with low testosterone are similarly vulnerable. Screening total and free testosterone before starting weight loss in men over 50 with symptoms of hypogonadism is reasonable, and replacement when indicated supports muscle preservation. A TrimRx clinician can coordinate this evaluation as part of the broader treatment plan.

What’s the Long-term Picture for Patients WHO Maintain Weight Loss?

Patients who maintain weight loss for 1 to 2 years typically see muscle mass stabilize and even rebuild modestly if they’re training consistently. The metabolic adaptations that come with sustained weight loss, lower resting metabolism and increased efficiency, are real but not catastrophic if muscle is preserved.

The patients who do best long-term aren’t those who lose the most weight fastest. They’re the ones who lose weight steadily, train through it, eat enough protein, and keep training after the active weight-loss phase ends. That pattern produces the durable metabolic improvements that GLP-1 therapy makes possible.

How Do Leucine and Other Amino Acids Fit In?

Leucine is the most anabolic of the essential amino acids. It triggers mTORC1, the cellular signal for muscle protein synthesis. A protein meal needs roughly 2.5 to 3 grams of leucine to maximally trigger muscle protein synthesis in adults, which translates to around 25 to 35 grams of high-quality protein per meal.

Older adults need slightly more leucine per meal because of “anabolic resistance,” a reduced sensitivity to amino acid signaling. Targeting 3 to 4 grams of leucine per meal (roughly 35 to 45 grams of protein) restores the response. Whey protein, eggs, dairy, fish, and lean meat hit these targets easily. Plant proteins are usable but typically require larger portion sizes or supplementation with leucine-rich sources like soy or hemp.

Spacing protein across 3 to 4 meals matters more than total daily intake. Loading all daily protein into one meal doesn’t produce as much net muscle protein synthesis as spreading it. For GLP-1 patients, who often eat less total food, careful protein distribution becomes especially important.

Bottom line: Protein intake of 1.2 to 1.6 g/kg/day plus resistance training preserves muscle during caloric deficit

FAQ

How Much Muscle Will I Lose on Semaglutide?

Average lean mass loss is roughly 25% to 40% of total weight loss, based on STEP 1 and STEP body composition data. Resistance training plus adequate protein can cut that to 10% to 20%.

Is the Muscle Loss Permanent?

No. Muscle responds well to training and protein intake at any age. Lost muscle can be regained if the person continues resistance training after the weight-loss phase ends.

How Much Protein Do I Need on a GLP-1?

1.2 to 1.6 grams per kilogram of body weight per day, split across 3 to 4 meals. For someone 80 kg, that’s roughly 100 to 130 grams of protein daily.

Will Resistance Training Make Me Hungrier?

It can stimulate appetite briefly, but GLP-1 medications suppress that response. Most patients on semaglutide or tirzepatide find that they can train normally without their hunger overshooting their daily targets.

Should Older Patients Avoid GLP-1s Because of Muscle Loss?

No, but they should be monitored more closely. Grip strength, gait speed, and functional independence are worth tracking. The benefits of weight loss in older adults with obesity usually outweigh the muscle risk if protein and training are addressed.

Are There Medications That Build Muscle Alongside GLP-1?

Bimagrumab and other activin receptor antagonists are in clinical development. Testosterone replacement in men with low levels is sometimes used adjunctively. None are FDA-approved specifically for use with GLP-1s yet.

What About Creatine on a GLP-1?

Creatine monohydrate at 3 to 5 grams daily is one of the best-studied supplements for muscle preservation and performance. There’s no interaction with GLP-1 medications, and the modest water retention from creatine doesn’t meaningfully affect weight-loss tracking. Most patients tolerate it well.

Should I Weigh Myself More or Less Often on a GLP-1?

Weekly weigh-ins capture the trend without the day-to-day noise of fluid shifts and gut emptying changes. For tracking body composition specifically, a DXA scan every 6 months is more informative than the scale.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.